At the news
? NEUTRALIMPACT 4/10 144 filed Jun 18, 2026 at 16:27 ET
Director John Quisel filed a Form 144 notice of intent to sell 34,000 shares of Disc Medicine (IRON), valued at approximately $2.39M based on the filing date. The shares are from the exercise of stock options, and the sale is planned as a cash transaction through Morgan Stanley. While a $2.39M sale by a director is notable, it is not an executive-chair-level event and may be part of routine portfolio diversification.
- Director John D. Quisel filed a Form 144 on June 18, 2026, signaling intent to sell 34,000 shares.
- The estimated aggregate value of the proposed sale is $2,387,140 (based on shares × price on filing date).
- Shares are from the exercise of stock options, not direct open-market accumulation.
- The sale would represent a small fraction of Quisel's total holdings (the filing references total securities outstanding of 38,199,089 shares, but Quisel's personal holdings are not disclosed in this filing).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access